- call +1-201-465-4211
- email sales@mrinsights.biz
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.
Scope of the Report:
This report focuses on the Influenza Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America and Europe are the largest consumers in influenza diagnostics and is expected to retain the higher growth rate during the next years due to strong growth in influenza diagnostics industry. China has witnessed a major chunk in influenza diagnostics in the Asia Pacific region. Actually, that is why manufacturers have several plants, usually close to aimed demand market.
All manufactures in the world are committed to the improvement of products. These two years, some of Chinese manufactures can almost catch up with the world's leading technology too. Most technologies are developed by the manufacturers instead of importing from other companies.
Many international manufacturers expand their business through building factories or investments in targeted markets. Also, many major players have built up plants in other countries.
The worldwide market for Influenza Diagnostics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Enigma Diagnostics
Focus Diagnostics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
RIDT
RT-PCR
Cell Culture
Market Segment by Applications, can be divided into
Hospitals
POCT
Others (Laboratory diagnosis, etc.)
There are 15 Chapters to deeply display the global Influenza Diagnostics market.
Chapter 1, to describe Influenza Diagnostics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Influenza Diagnostics, with sales, revenue, and price of Influenza Diagnostics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Influenza Diagnostics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Influenza Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Influenza Diagnostics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Influenza Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 RIDT
1.2.2 RT-PCR
1.2.3 Cell Culture
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 POCT
1.3.3 Others (Laboratory diagnosis, etc.)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 BD
2.1.1 Business Overview
2.1.2 Influenza Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BD Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott (Include Alere)
2.2.1 Business Overview
2.2.2 Influenza Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott (Include Alere) Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche
2.3.1 Business Overview
2.3.2 Influenza Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 SIEMENS
2.4.1 Business Overview
2.4.2 Influenza Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 SIEMENS Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Analytik Jena
2.5.1 Business Overview
2.5.2 Influenza Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Analytik Jena Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Quidel
2.6.1 Business Overview
2.6.2 Influenza Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Quidel Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Thermo Fisher
2.7.1 Business Overview
2.7.2 Influenza Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Thermo Fisher Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Meridian Bioscience
2.8.1 Business Overview
2.8.2 Influenza Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Meridian Bioscience Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 BioMerieux
2.9.1 Business Overview
2.9.2 Influenza Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 BioMerieux Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sekisui Diagnostics
2.10.1 Business Overview
2.10.2 Influenza Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sekisui Diagnostics Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Response Biomedical
2.11.1 Business Overview
2.11.2 Influenza Diagnostics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Response Biomedical Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 SA Scientific
2.12.1 Business Overview
2.12.2 Influenza Diagnostics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 SA Scientific Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Enigma Diagnostics
2.13.1 Business Overview
2.13.2 Influenza Diagnostics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Enigma Diagnostics Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Focus Diagnostics
2.14.1 Business Overview
2.14.2 Influenza Diagnostics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Focus Diagnostics Influenza Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Influenza Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Influenza Diagnostics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Influenza Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Influenza Diagnostics Manufacturer Market Share in 2017
3.3.2 Top 6 Influenza Diagnostics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Influenza Diagnostics Market Analysis by Regions
4.1 Global Influenza Diagnostics Sales, Revenue and Market Share by Regions
4.1.1 Global Influenza Diagnostics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Influenza Diagnostics Revenue and Market Share by Regions (2013-2018)
4.2 North America Influenza Diagnostics Sales and Growth Rate (2013-2018)
4.3 Europe Influenza Diagnostics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Influenza Diagnostics Sales and Growth Rate (2013-2018)
4.5 South America Influenza Diagnostics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Influenza Diagnostics Sales and Growth Rate (2013-2018)
5 North America Influenza Diagnostics by Countries
5.1 North America Influenza Diagnostics Sales, Revenue and Market Share by Countries
5.1.1 North America Influenza Diagnostics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Influenza Diagnostics Revenue and Market Share by Countries (2013-2018)
5.2 United States Influenza Diagnostics Sales and Growth Rate (2013-2018)
5.3 Canada Influenza Diagnostics Sales and Growth Rate (2013-2018)
5.4 Mexico Influenza Diagnostics Sales and Growth Rate (2013-2018)
6 Europe Influenza Diagnostics by Countries
6.1 Europe Influenza Diagnostics Sales, Revenue and Market Share by Countries
6.1.1 Europe Influenza Diagnostics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Influenza Diagnostics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Influenza Diagnostics Sales and Growth Rate (2013-2018)
6.3 UK Influenza Diagnostics Sales and Growth Rate (2013-2018)
6.4 France Influenza Diagnostics Sales and Growth Rate (2013-2018)
6.5 Russia Influenza Diagnostics Sales and Growth Rate (2013-2018)
6.6 Italy Influenza Diagnostics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Influenza Diagnostics by Countries
7.1 Asia-Pacific Influenza Diagnostics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Influenza Diagnostics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Influenza Diagnostics Revenue and Market Share by Countries (2013-2018)
7.2 China Influenza Diagnostics Sales and Growth Rate (2013-2018)
7.3 Japan Influenza Diagnostics Sales and Growth Rate (2013-2018)
7.4 Korea Influenza Diagnostics Sales and Growth Rate (2013-2018)
7.5 India Influenza Diagnostics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Influenza Diagnostics Sales and Growth Rate (2013-2018)
8 South America Influenza Diagnostics by Countries
8.1 South America Influenza Diagnostics Sales, Revenue and Market Share by Countries
8.1.1 South America Influenza Diagnostics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Influenza Diagnostics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Influenza Diagnostics Sales and Growth Rate (2013-2018)
8.3 Argentina Influenza Diagnostics Sales and Growth Rate (2013-2018)
8.4 Colombia Influenza Diagnostics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Influenza Diagnostics by Countries
9.1 Middle East and Africa Influenza Diagnostics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Influenza Diagnostics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Influenza Diagnostics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Influenza Diagnostics Sales and Growth Rate (2013-2018)
9.3 UAE Influenza Diagnostics Sales and Growth Rate (2013-2018)
9.4 Egypt Influenza Diagnostics Sales and Growth Rate (2013-2018)
9.5 Nigeria Influenza Diagnostics Sales and Growth Rate (2013-2018)
9.6 South Africa Influenza Diagnostics Sales and Growth Rate (2013-2018)
10 Global Influenza Diagnostics Market Segment by Type
10.1 Global Influenza Diagnostics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Influenza Diagnostics Sales and Market Share by Type (2013-2018)
10.1.2 Global Influenza Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 RIDT Sales Growth and Price
10.2.1 Global RIDT Sales Growth (2013-2018)
10.2.2 Global RIDT Price (2013-2018)
10.3 RT-PCR Sales Growth and Price
10.3.1 Global RT-PCR Sales Growth (2013-2018)
10.3.2 Global RT-PCR Price (2013-2018)
10.4 Cell Culture Sales Growth and Price
10.4.1 Global Cell Culture Sales Growth (2013-2018)
10.4.2 Global Cell Culture Price (2013-2018)
11 Global Influenza Diagnostics Market Segment by Application
11.1 Global Influenza Diagnostics Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 POCT Sales Growth (2013-2018)
11.4 Others (Laboratory diagnosis, etc.) Sales Growth (2013-2018)
12 Influenza Diagnostics Market Forecast (2018-2023)
12.1 Global Influenza Diagnostics Sales, Revenue and Growth Rate (2018-2023)
12.2 Influenza Diagnostics Market Forecast by Regions (2018-2023)
12.2.1 North America Influenza Diagnostics Market Forecast (2018-2023)
12.2.2 Europe Influenza Diagnostics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Influenza Diagnostics Market Forecast (2018-2023)
12.2.4 South America Influenza Diagnostics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Influenza Diagnostics Market Forecast (2018-2023)
12.3 Influenza Diagnostics Market Forecast by Type (2018-2023)
12.3.1 Global Influenza Diagnostics Sales Forecast by Type (2018-2023)
12.3.2 Global Influenza Diagnostics Market Share Forecast by Type (2018-2023)
12.4 Influenza Diagnostics Market Forecast by Application (2018-2023)
12.4.1 Global Influenza Diagnostics Sales Forecast by Application (2018-2023)
12.4.2 Global Influenza Diagnostics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Influenza Diagnostics Picture
Table Product Specifications of Influenza Diagnostics
Figure Global Sales Market Share of Influenza Diagnostics by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
